🇺🇸 FDA
Patent

US 11033569

Compounds,Compositions, and methods for the treatment of disease

granted A61KA61K2039/55511A61K31/7084

Quick answer

US patent 11033569 (Compounds,Compositions, and methods for the treatment of disease) held by Sperovie Biosciences, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sperovie Biosciences, Inc.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/55511, A61K31/7084, A61K39/12, A61K39/39